US Archives - Page 46 of 101 - European Medical Journal

Twice-Yearly HIV Prevention Shot Nears FDA Decision

The U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for the first-ever twice-yearly injectable HIV prevention therapy.

New Therapy Hope for Hard-to-Treat DLBCL

A new treatment combination has emerged for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplant (ASCT).

The Surprising Link Between Almond Consumption and Gut Health

Almond consumption and gut health may be linked and demonstrate the role of the microbiome in cardiometabolic health, according to a recent review.

The Evolution of Tuberculosis Isolation Practices

A new study explores the evolution of tuberculosis isolation, from early misconceptions to modern airborne transmission guidelines. See how TB control measures have changed.

Navigating Challenges in Cardiac Device Infections

Cardiac implantable electronic device infections (CIEDIs) pose significant challenges in diagnosis and management for healthcare professionals.

Do Obesity, Diabetes, Smoking Affect Surgical Outcomes in Hidradenitis Suppurativa?

A recently published review examined the impact of obesity, diabetes, and smoking on surgical outcomes for patients with hidradenitis suppurativa (HS).

Cognitive Activity in Midlife and Late Life Lowers Alzheimer’s Risk

Engaging in mentally stimulating activities in midlife and late life is linked to a lower risk of Alzheimer’s disease (AD), according to a study from the Chicago Health and Aging Project.

How To Better Guide Patient Management in Aggressive Lymphoma: New Data on PET/CT

18F-FDG PET and PET/CT scans show strong diagnostic accuracy in detecting histological transformations (HT) in indolent lymphomas, including Richter’s transformation (RT) in chronic lymphocytic leukemia (CLL), according to a new meta-analysis.

Pediatric CF Therapy Enhances Airway Function

A real-world study from the Netherlands has shared the benefits of lumacaftor/ivacaftor (lum/iva) in children with cystic fibrosis (CF) homozygous for the F508del mutation.

Cardiovascular Imaging Breakthroughs for Rheumatic Disease

A recent study evaluated the advantages and limitations of various noninvasive imaging modalities in diagnosing cardiovascular disease (CVD) in patients with autoimmune rheumatic diseases (ARDs).